JeffreyFPattonMD

PubMed

• 1 citations
  Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
  Toni S. Perry, Natalie R. Dickson, Jeffrey F. Patton> ;Future Oncology. 2020 Jan 27
• 7 citations
  Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?
  Sari Hopson, Adrianne Waldman Casebeer, Stephen Stemkowski, Dana Drzayich Antol, Zhuliang Tao, Andrew M. Howe, Jeffrey Patton, Art Small, Anthony Masaquel> ;Journal of Medical Economics. 2018 Feb 1
• 2 citations
  Use of a Case Management System to Reduce the Response Time for Symptom Management Calls in a High-Volume Practice
  Natalie R. Dickson, Larry Edward Bilbrey, Pamela E. Lesikar, Laura Kaufman, Linda F. Hays, Ansley T. Tillman, Aaron J. Lyss, Martha J. Sarratt, David W. Scrugham, Angi...> ;Journal of Oncology Practice. 2016 Aug 30
• 10 citations
  A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors
  Johanna C. Bendell, Suzanne F. Jones, Lowell L. Hart, Shubham Pant, Adil Moyhuddin, Cassie M. Lane, Chris Earwood, Patrick Murphy, Jeffrey Patton, William Charles Penl...> ;Cancer Investigation. 2015 Oct 13
• Characterization of hydrogen responsive nanoporous palladium films synthesized via a spontaneous galvanic displacement reaction.
  Patton, J. F., Lavrik, N. V., Joy, D. C., Hunter, S. R., Datskos, P. G., Smith, D. B., Sepaniak, M. J.> ;Nanotechnology. 2012 Nov 23
• Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer.
  Spigel, D.R., Hainsworth, J.D., Barton, J.H., Patton, J.F., Zubkus, J.D., Simons, L., Griner, P., Burris, H.A., Greco, F.A.> ;J Thorac Oncol. 2010 Jun
• 213 citations
  Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab
  David R. Spigel, John D. Hainsworth, Denise A. Yardley, Eric L. Raefsky, Jeffrey Patton, N. W. Peacock, C. Farley, Howard A. Burris, F. Anthony Greco> ;Journal of Clinical Oncology. 2010 Jan 1
• Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC).
  Spigel DR, Hainsworth JD, Farley C, Meng C, Blake D, Burris HA, Raefsky E, Patton J, Hart LL, Greco FA> ;J. Clin. Oncol.. 2008-05-20
• Topotecan, paclitaxel, and carboplatin in advanced ovarian cancer: A phase II trial of the Minnie Pearl Cancer Research Network.
  Zubkus JD, Hainsworth JD, Spigel DR, Patton JF, Shipley DL, Baskette M, Schnell F, Greco FA> ;J. Clin. Oncol.. 2006-06-20
• Preoperative oxaliplatin (O), docetaxel (D), capecitabine (C), and concurrent radiation therapy (RT) for patients (pts) with localized esophageal cancer: A phase I/II ...
  Barnes EK, Spigel DR, Greco FA, Meluch AA, Yardley DA, Burris HA, Shipley DL, Patton JF, Farley C, Hainsworth JD> ;J. Clin. Oncol.. 2006-06-20
• A phase II trial of biweekly pemetrexed (P) and gemcitabine (G) in the first-line treatment (tx) of patients (pts) with advanced non-small cell lung cancer (NSCLC).
  Peacock NW, Spigel DR, Hainsworth JD, Yardley DA, Burris HA, Barton JH, Patton JF, Shipley DL, Simons L, Greco FA> ;J. Clin. Oncol.. 2006-06-20
• Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC):...
  Patton JF, Spigel DR, Greco FA, Liggett WH, Zubkus JD, Baskette M, Schreeder M, Woytowitz D, Nelson E, Hainsworth JD> ;J. Clin. Oncol.. 2006-06-20
• 15 citations
  A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.
  Jeffrey F Patton, Toni Sullivan, Yeung-Chul Mun, Timothy Reeves, Greg Rossi, Joel F. Wallace> ;The Journal of Supportive Oncology. 2005 Nov 1
• 2 citations
  Advances in conducting retrospective chart review studies: use of electronic report forms and database in a community study in anemic patients with myelodysplastic syn...
  Toni Sullivan, Yeung-Chul Mun, Joel F. Wallace, Jeffrey F Patton> ;The Journal of Supportive Oncology. 2005 Nov 1
• Bevacizumab, erlotinib, and imatinib in the treatment of patients (pts) with advanced renal cell carcinoma (RCC): A Minnie Pearl Cancer Research Network phase I/II trial.
  Hainsworth JD, Sosman JA, Spigel DR, Patton JF, Thompson DS, Sutton V, Hart LL, Yost K, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• Effectiveness of darbepoetin alfa 200 mcg every 2 weeks (Q2W) for the treatment of anemia in myelodysplastic syndrome (MDS).
  Patton J, Sullivan T, Mun Y, Wallace J> ;J. Clin. Oncol.. 2005-06-01
• 44 citations
  Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice.
  Jeffrey Patton, Timothy Reeves, Joel F. Wallace> ;The Oncologist. 2004 Jul 1
• Weekly bolus topotecan as first-line therapy for extensive stage small cell lung cancer in patients who are elderly, poor performance status, or have severe coexistent...
  Patton JF, Hainsworth JD, Spigel DR, Burris HA, Yardley DA, Morrissey LH, Sylvester L, Dannaher C, Shipley DL, Greco FA> ;J. Clin. Oncol.. 2004-07-15
• 34 citations
  Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy
  Jeffrey Patton, Michael Kuzur, William Liggett, Fernando Miranda, Helen Varsos, Lester Porter> ;The Oncologist. 2004 Feb 1
• 1 citations
  Combination Cisplatin and Carboplatin in Advanced Squamous Cell Carcinoma of the Head and Neck
  Jeffrey F. Patton, Bayard L. Powell, Douglas R. White, Gregory B. Russell, Robin Inabinet, Hyman B. Muss> ;Cancer Investigation. 1996 Jan 1
• 35 citations
  Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura
  Jeffrey F. Patton, Kenneth R. Manning, Douglas Case, John Owen> ;American Journal of Hematology. 1994 Oct 1
• A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.
  Yardley, D. A., McCleod, M., Schreiber, F., Murphy, P., Patton, J., Thompson, D. S., Shastry, M., Rubin, M., Melnik, M., Burris, H. A., Hainsworth, J. D.> ;Cancer Invest. 2010 Nov
• Join now to see all